BeatO, a comprehensive digital care platform for controlling and reversing Diabetes, founded by Gautam Chopra, Yash Sehgal and Kunal Kinalekar, has bagged about $33 million in Series B funding led by Lightrock India. HealthQuad, Flipkart Ventures and existing investors also took part in the latest fund raise.

Further, the company will deploy the fresh fund to expand BeatO’s diabetes care programs pan-India, invest in strengthening their leadership team and to invest in BeatO’s product and technology. It will also continue to build the evidence base for its care programs, setting the standard of care globally for diabetes. Furthermore, it intends to serve over 10 million patients by 2025, becoming India’s largest Diabetes Care Company.

Commenting on the latest funding, Gautam Chopra, Co-Founder and CEO, BeatO said, “With our digital-first solution, BeatO is well positioned to lay the new standards of how care will be delivered in the future to millions of Indians. We are pleased to have a fantastic set of partners joining us on the journey who deeply resonate with our vision and bring solid capabilities to help us achieve our goal.”

Tejasvi Ravi, Leads, healthcare investments at Lightrock India added, “BeatO is on an ambitious mission to re-design how diabetes is cared for in India. They are a world-class team that have demonstrated the ability to deliver consistent, high-quality and empathetic care resulting in clinical outcomes that are outstanding.”

Company’s existing marquee investors include Orios Venture Partners, Leo Capital, W Health Ventures, Blume Ventures and others.

Categories: Other News